Table 1

Characteristics of patients diagnosed with first-time psoriatic arthritis (PsA) in Denmark, all specialties

PsA—diagnoses from all specialties
19971999200120032005200720092011
n%n%n%n%n%n %n%n%
Population 5 799 6265 796 3015 790 4405 775 6435 763 5875 748 7525 730 7285 699 167
Women 2 929 40450.52 925 81450.52 920 59150.42 910 52750.42 902 51450.42 893 29550.32 882 81450.32 866 06350.3
Men 2 870 22249.52 870 48749.52 869 84949.62 865 11649.62 861 07349.62 855 45749.72 847 91449.72 833 10449.7
PsA
Mean age, years 47.748.048.047.847.248.648.749.7
Any 3760.014660.014470.015660.017140.018940.0211180.0211280.02
Women 21557.226857.524254.132056.539655.549755.665958.965558.1
Men 16142.819842.520545.924643.531844.539744.445941.147341.9
Age groups
0–19 82.1102.1173.8295.1253.5353.9443.9423.7
20–29 277.2418.8439.6458.0679.4626.9776.9857.5
30–39 7519.99019.37817.49617.013619.014316.019117.118416.3
40–49 9525.311925.510423.312421.916623.221924.525522.825722.8
50–59 10929.010723.011225.115627.619226.924127.030227.025422.5
60–69 3910.45812.45111.47212.78612.012213.617916.019217.0
≥70 236.1418.8429.4447.8425.9728.1706.311410.1
Systemic Tx*
Any 16343.416836.118340.925745.433747.243148.253647.950444.7
Non-biologic 16343.416836.118340.925745.433747.241646.549644.447942.5
Biologic 00.000.000.000.060.8323.6988.8797.0
  • *Systemic Tx: methotrexate, leflunomide, ciclosporin, sulfasalazine, etanercept, infliximab, adalimumab, certolizumab pegol, golimumab, ustekinumab.

  • Tx, therapy.